✦ LIBER ✦

Targeting CCL11 in the treatment of ovarian cancer

✍ Scribed by Nolen, Brian M; Lokshin, Anna E

Book ID: 120453797
Publisher: Informa plc
Year: 2010
Tongue: English
Weight: 252 KB
Volume: 14
Category: Article
ISSN: 1472-8222
DOI: 10.1517/14728220903512983

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Targeting angiogenesis in ovarian cancer

✍ Jordan Schmitt; Daniela Matei 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 309 KB

Targeting genetic and epigenetic alterat

Targeting genetic and epigenetic alterations in the treatment of serous ovarian cancer

✍ Johanne I. Weberpals; Madhuri Koti; Jeremy A. Squire 📂 Article 📅 2011 🏛 Elsevier 🌐 English ⚖ 437 KB

The role of targeted therapy in ovarian

The role of targeted therapy in ovarian cancer

✍ Susana Banerjee; Stan Kaye 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 286 KB

Bevacizumab in the Treatment of Ovarian

Bevacizumab in the Treatment of Ovarian Cancer

✍ Florian Heitz, Philipp Harter, Jana Barinoff, Bianca Beutel, Paevi Kannisto, Jac 📂 Article 📅 2012 🏛 Springer Healthcare Communications 🌐 English ⚖ 963 KB

The potential to target CCL5/CCR5 in bre

The potential to target CCL5/CCR5 in breast cancer

✍ Velasco-Velázquez, Marco; Xolalpa, Wendy; Pestell, Richard G 📂 Article 📅 2014 🏛 Informa plc 🌐 English ⚖ 619 KB

Targeting Aurora Kinase Inhibits Tumorig

Targeting Aurora Kinase Inhibits Tumorigenesis in Ovarian Cancer

✍ Y.G. Lin; W.M. Merritt; D.J. Fiterman; G.N. Armaiz-Pena; N.B. Jennings; W.A. Spa 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 106 KB